Hovione's $35M CDC Flex line links spray drying to tablets, designed to eliminate scale-up under FDA Q13 guidance.
News|Webcasts|August 20, 2025
Strengthening Your Supply Chain: The Power of Dual Sourcing Pharmaceutical Packaging
Author(s)Datwyler
Listen
0:00 / 0:00
Webinar Date/Time: Tue, Sep 23, 2025 9:00 AM EDT
Ensure uninterrupted supply and mitigate risks—the twin pillars of a resilient pharmaceutical value chain. Discover how implementing a strategic dual sourcing approach can significantly mitigate risks, ensure business continuity, and enhance the security of your critical component supply.
Register Free:
Event Overview:
In today’s unpredictable landscape, a resilient pharmaceutical packaging supply chain isn’t just an advantage—it’s a necessity. Datwyler invites you to its exclusive webinar to explore the strategic imperative of dual sourcing, offering insights into how this approach can derisk your operations, ensure consistent supply of critical packaging components, and provide the flexibility needed in a dynamic market. Don’t miss this opportunity to build a more robust and reliable supply chain.
Key Learning Objectives:
- Understand why dual sourcing is key to derisking your pharma packaging supply
- Gain actionable strategies to ensure an uninterrupted flow of critical components and reduce operational vulnerabilities.
- Discover how diversifying your supplier base creates a flexible and robust pharmaceutical supply chain, ready for any market dynamic
Who Should Attend:
- Quality/regulatory personnel in parenteral drug delivery
- Formulation scientists and packaging engineers
- Device development engineers and managers
- Personnel in technical functions surrounding drug delivery systems
- Experts on extractables and leachables
- Procurement professionals
Speaker:
Gabrielle Gehron joined Datwyler Healthcare in 2022 as a Scientific Support Manager, quickly graduating in 2023 to Technical and Scientific Expert. In 2025, she became Datwyler’s first Knowledge Manager and now creates technical presentations and documentation for customers globally. With 2 degrees in biomedical engineering and 6 years in the parenteral packaging space, she helps major drug companies safely package their products.
Register Free:
Related to this article
This week on PharmTech, Merck diversified its pipeline, USP emphasizes supply chain security, AI systems are examined, and speakers preview their presentations at CPHI Milan and AAPS PharmSci 360.
Capsugel's Bram Baert and Sandrine Picco argue that chasing zero nitrite in pharmaceutical excipients is often impractical and costly. They recommend setting scientifically justified, risk-based limits and consistently staying below them.
Ron Scarboro, Azurity Pharmaceuticals, claims drug reformulation that removes patient barriers must preserve efficacy, urging early cross-functional team alignment.
PharmTech AI Pulse Check episode 2 covers AI data governance, API-gated journals, watermarking limits, and why attribution beats detection in GxP.
The FDA opened an expedited IND pilot, tightened scrutiny of foreign trial data, and finalized a rule recognizing non-animal testing methods. In Europe, the EMA advanced pharmaceutical legislation reform, restricted 2 legacy products, and opened an injectable-iron safety review.
Novartis licenses Abogen's mRNA-encoded T-cell engager for autoimmune disease, raising scale-up questions for mRNA-lipid nanoparticle manufacturing.
Pharma manufacturing spent 90 years learning that producing correct outputs isn't the same as catching your own errors. AI has only learned the first.